The study of cytokines by Japanese researchers : a historical perspective
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-05-01
著者
-
Kumanogoh Atsushi
Department of Immunopathology, Research Institute for Microbial Diseases, Osaka University
-
Ogata Masato
Department Of Computer Science And Communication Engineering Kyushu Univ.
-
Ogata Masato
Department Of Biochemistry And Proteomics Division Of Genomics And Regenerative Biology Mie Universi
-
Kumanogoh Atsushi
Department Of Immunopathology Immunology Frontier Research Center (ifrec) Research Institute For Mic
関連論文
- Semaphorins and their receptors: Novel features of neural guidance molecules
- CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells
- Requirement for CD100-CD72 interactions in fine-tuning of B-cell antigen receptor signaling and homeostatic maintenance of the B-cell compartment
- Plexin-A4 negatively regulates T lymphocyte responses
- Bimodal regulation of T cell-mediated immune responses by TIM-4
- Dissection of B cell differentiation during primary immune responses in mice with altered CD40 signals
- Involvement of CD100, a lymphocyte semaphorin, in the activation of the human immune system via CD72 : implications for the regulation of immune and inflammatory responses
- On the Stability of Operating Points of Transistor Circuits
- Effect of Sesamin in Acanthopanax senticosus HARMS on Behavioral Dysfunction in Rotenone-Induced Parkinsonian Rats(Pharmacognosy)
- On the potential instablity of an RC active filter with op-amps
- The study of cytokines by Japanese researchers : a historical perspective
- OE-356 Novel Transmembrane Type Class VI Semaphorin, Sema6D Regulates Cardiac Morphogenesis Through PlexinA1(Development and Differentiation 2 (H) : OE45)(Oral Presentation (English))
- A case of Behcet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab
- Drug-induced Thrombotic Thrombocytopenic Purpura Successfully Treated with Recombinant Human Soluble Thrombomodulin
- Tocilizumab for the Treatment of Patients With Refractory Takayasu Arteritis